IrisVision

IrisVision

Private
Pleasanton, CaliforniaHealthcare & Life Scienceshttps://irisvision.com

Last Round

Series A

Mar 20, 2022

Total Funding Raised

$18.2M

Momentum Score

25 /100

Company Overview

IrisVision is a digital health technology company that develops and manufactures wearable devices to assist individuals with low vision. Its products, which are FDA-registered Class I medical devices, utilize augmented reality and a smartphone integrated into a headset to enhance remaining sight for people with conditions such as Macular Degeneration, Diabetic Retinopathy, and Stargardt's Disease. The company was incorporated in 2016 following research by Dr. Frank Werblin at UC Berkeley and collaboration with experts at Johns Hopkins University. IrisVision is a venture-backed company that aims to make vision health solutions accessible globally.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, Consumer Electronics, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

low vision aidassistive technologyvision enhancementwearable devicesmart glasseselectronic glassesmacular degenerationdiabetic retinopathycomputer visionoptical character recognitionOCRdigital magnifiermedical devicetext-to-speechretinitis pigmentosaVA contractVR for low vision

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IrisVision Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

IrisVision Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 20, 2022
SeedDec 12, 2019
GrantDec 12, 2019

IrisVision Investors

Notable investors and investment history

InvestorRounds
Hanawa GroupSeries A
Social StartsSeries A
Band of AngelsSeries A, Seed
Outcomes CollectiveSeries A

IrisVision Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

IrisVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about IrisVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersPleasanton, California
Employee Range13
Year Founded2016
Last FundingMar 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.